Project Grant R01DA061338
Award Date
6/1/25
Completion Date
2/28/29
Dollars Obligated
$883K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
The National Institutes of Health's National Institute on Drug Abuse awarded New York University School of Medicine a $1,446,310 Project Grant under the Drug Abuse and Addiction Research Programs to adapt an evidence-based posttraumatic stress disorder intervention for polysubstance use populations receiving treatment for opioid use disorder. Specifically, the award will support adapting an existing trauma-focused therapy, Skills Training in Affective and Interpersonal Regulation with...
This federal Project Grant award of $798,605 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to develop and test an adapted version of Written Exposure Therapy (WEST) for treating post-traumatic stress disorder (PTSD) among individuals with opioid use disorder (OUD) receiving residential substance use disorder (SUD) treatment. The project will involve obtaining stakeholder feedback, developing an initial WEST adaptation, refining the...
This $2,729,018 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and evaluate a mobile health intervention for individuals with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry after residential treatment. The grant supports a ground-up approach to rigorously develop and evaluate a mobile app with both on-demand (24/7 PTSD-OUD...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop efficient statistical methods for data fusion to improve the power and external validity of clinical trials for treating opioid use disorder. The $564,326 award, with a performance period from August 2024 to May 2029, will fund the development of new parametric and semiparametric estimators for average treatment effects,...
This federal Project Grant award of $107,002 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a cross-sectional, quantitative study to measure the impact of racism-related experiences, including major discriminatory events, racial microaggressions, internalized racism, and historical trauma, on post-traumatic stress disorder (PTSD) symptoms and polysubstance use among a sample of 300 Black young adults. The study...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a 5-year, $2,663,022 study to test the effectiveness, implementation, and cost of Cognitive Processing Therapy adapted for criminal justice settings (CPT-CJ) in reducing post-incarceration drug use, mental health symptoms, and drug-related crime. The study will be conducted by the University of Arkansas for Medical Sciences (UAMS) and enroll 640...
This Project Grant award, totaling $181,040.00, was issued by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award aims to create an immersive training experience for the applicant to develop a unique skillset at the intersection of psychiatric genetics, substance use disorder (SUD) epidemiology and health disparities, SUD psychopharmacology, clinical informatics, and bioinformatics. The research will leverage the Million Veteran...
This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $385,000.00 in funding to Loyola University of Chicago's Health Sciences Campus to conduct research on integrated treatment approaches for patients with co-occurring opioid use disorder (OUD) and alcohol use disorder (AUD). The key objectives of this research project are to: 1) assess the effectiveness of integrated treatment regimens,...
This federal Project Grant award of $1,873,868 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to design and conduct a hybrid efficacy-implementation randomized control trial to improve substance use disorder (SUD) treatment retention among pregnant patients. The key products and services to be delivered include: Developing and piloting protocols to (1) systematically address social determinants of health (SDOH) and link...